Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Thomas U. Ahearn(Harvard University), Åslaug Helland(Oslo University Hospital), Olav Engebråten(University of Oslo), Marina Bermisheva(Russian Academy of Sciences), Angela Brooks‐Wilson(BC Cancer Agency), Federico Canzian(German Cancer Research Center), Volker Arndt(German Cancer Research Center), Michael Lush(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Thomas Brüning(Institute for Prevention and Occupational Medicine), Jose E. Castelao(Servicio Gallego de Salud), Jenny Chang‐Claude(Universität Hamburg), Kristin V. Reinertsen(Oslo University Hospital), Cecile E. Kiserud(University of Southampton), Heiko Becher(Universität Hamburg), Joe Dennis(University of Cambridge), Kristine Kleivi Sahlberg(University of Oslo), Alison M. Dunning(University of Cambridge), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Roger L. Milne(The University of Melbourne), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Christine L. Clarke(Memorial University of Newfoundland), Alexander Fosså(Oslo University Hospital), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carl Blomqvist(University of Helsinki), Adinda Baten(KU Leuven), Marit Muri Holmen(Unknown), Vilde Drageset Haakensen(University of Oslo), Toril Sauer(Leiden University Medical Center), Stig E. Bojesen(University of Copenhagen), Saundra S. Buys(University of Utah), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Lars Ottestad(Norwegian Cancer Society), Bernardo Bonanni(European Institute of Oncology), Rolf Kåresen(Oslo University Hospital), Kristan J. Aronson(Queen's University), Stephen J. Chanock(National Cancer Institute), Qin Wang(University of Cambridge), Haoyu Zhang(National Institutes of Health), Ellen Schlichting(Oslo University Hospital), Barbara Burwinkel(German Cancer Research Center), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Bjørn Naume(Norwegian Cancer Society), Manjeet K. Bolla(University of Cambridge), Annelie Augustinsson(Lund University)
Cited by 32
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k